SCHEMBL1659092

SCHEMBL1659092

Cc1c(F)sc(C(=O)O)c1-c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.46
GRIA4 P48058 1/20 0.44
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
FABP4 P15090 2/20 0.40
FABP3 P05413 1/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
POLB P06746 1/20 0.39
MAPT P10636 1/20 0.39
CRHBP P24387 1/20 0.39
CRHR2 Q13324 1/20 0.39
PTPRF P10586 1/20 0.39
PTPN1 P18031 1/20 0.39
ALDH1A1 P00352 3/20 0.38
GPR35 Q9HC97 2/20 0.38
GAA P10253 1/20 0.38
HPGD P15428 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
GRM6 O15303 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL69825 0.77 GRIA4 (0.50) SMN1; SMN2GRIA4CYP2C9CYP2C19MEN1
SCHEMBL17013379 0.73 CHRNA7 (0.54) SMN1; SMN2GRIA4FABP4FABP3MEN1
SCHEMBL14246796 0.70 MCL1 (0.48) SMN1; SMN2CYP2C19FABP4FABP3MEN1
Thiophene SCHEMBL27729425 0.69 GRIA4 (0.44) SMN1; SMN2GRIA4CYP2C9CYP2C19MEN1
SCHEMBL25211130 0.69 CYP2C9 (0.48) GRIA4CYP2C9CYP2C19ALDH1A1GPR35
SCHEMBL20015932 0.68 BCL2L1 (0.52) GRIA4CYP2C9CYP2C19MAPTPTPN1
SCHEMBL2958622 0.68 MCL1 (0.61) GRIA4CYP2C9CYP2C19FABP4MEN1
SCHEMBL6277250 0.68 POLB (0.50) SMN1; SMN2GRIA4CYP2C19FABP4KMT2A
SCHEMBL25220193 0.68 CYP2C9 (0.39) SMN1; SMN2GRIA4CYP2C9CYP2C19MAPT
SCHEMBL31015920 0.68 CYP2C9 (0.39) SMN1; SMN2GRIA4CYP2C9CYP2C19MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2307394-A2 NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME Amorepacific Corporation (KR) 2011-04-13 EP disclosed
WO-2010002209-A2 NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AMOREPACIFIC CORPORATION (KR) 2010-01-07 WO disclosed